Wegovy users keep weight off for four years, Novo Nordisk study says ReutersWhat the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and heart protection CNNPeople on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says CNBCWeight loss drug could reduce heart attack risk by 20%, study finds The GuardianOzempic Drug Semaglutide Could Cut Heart Risk By 20%—Regardless Of Weight Loss, Study Finds Forbes